Cite
HARVARD Citation
Anderson, E. et al. (2017). Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment. Journal for immunotherapy of cancer. 5 (1), p. . [Online].